Article Versions Notes

Harari A, Sarivalasis A, de Jonge K, Thierry A-C, Huber F, Boudousquie C, Rossier L, Orcurto A, Imbimbo M, Baumgaertner P, et al. A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma. Cancers. 2021; 13(22):5801. https://doi.org/10.3390/cancers13225801

Harari, Alexandre, Apostolos Sarivalasis, Kaat de Jonge, Anne-Christine Thierry, Florian Huber, Caroline Boudousquie, Laetitia Rossier, Angela Orcurto, Martina Imbimbo, Petra Baumgaertner, and et al. 2021. "A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma" Cancers 13, no. 22: 5801. https://doi.org/10.3390/cancers13225801

Harari, A., Sarivalasis, A., de Jonge, K., Thierry, A. -C., Huber, F., Boudousquie, C., Rossier, L., Orcurto, A., Imbimbo, M., Baumgaertner, P., Bassani-Sternberg, M., & Kandalaft, L. E. (2021). A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma. Cancers, 13(22), 5801. https://doi.org/10.3390/cancers13225801